FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/01/004310 [Registered on: 15/01/2014] Trial Registered Retrospectively
Last Modified On: 31/12/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Soap]  
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   A Clinical Study to evaluate the efficacy and safety of a Skin Lightening Soap for the treatment of Hyper Pigmentation in adults 
Scientific Title of Study   A Prospective, Open-labeled, Clinical Study to evaluate the efficacy and safety of a Skin Lightening Soap for the treatment of Hyper Pigmentation in adults 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
ICBio/CR/KOP/0415/24,Version 01 dated 14.MAY.2013  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr J Prasad 
Designation  Consultant Dermatologist 
Affiliation  Revive Cosmetic Clinique 
Address  Revive Cosmetic Clinique No.72, 2nd Road, Nandidurga Extn, Jayamahal Bangalore 560 046

Bangalore
KARNATAKA
560 046
India 
Phone  9844061806  
Fax    
Email  revive_cos@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Harisha S 
Designation  Director 
Affiliation  ICBio Clinical research Pvt Ltd 
Address  ICBio Clinical Research Pvt. Ltd. #16, ICBio Tower, Yelahanka Main Road Chikkabetahalli, Vidyaranyapura,Bangalore.

Bangalore
KARNATAKA
560097
India 
Phone  9900111997  
Fax    
Email  harish@icbiocro.com  
 
Details of Contact Person
Public Query
 
Name  Dr Harisha S 
Designation  Director 
Affiliation  ICBio Clinical research Pvt Ltd 
Address  ICBio Clinical Research Pvt. Ltd. #16, ICBio Tower, Yelahanka Main Road Chikkabetahalli, Vidyaranyapura,Bangalore.

Bangalore
KARNATAKA
560097
India 
Phone  9900111997  
Fax    
Email  harish@icbiocro.com  
 
Source of Monetary or Material Support  
Kumar Organic Products Research Center 
 
Primary Sponsor  
Name  Kumar Organic Products Research Center 
Address  Plot No.36, Road No. 3 Road No.3&5, Jigani Industrial Area, Anekal Taluk, Bangalore - 562 106 India. 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr J Prasad  Revive Cosmetic Clinique  #72, 2nd Road, Nandidurga Extn, Jayamahal Bangalore – 560 046
Bangalore
KARNATAKA 
9844061806

revive_cos@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Clinical IEC Bangalore  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Healthy Human Volunteers  hyper pigmentation disorders such as Melasma and lentigo (mild to moderate).  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
Intervention  Skin Lightening Soap  Deep wash: Wash the face, neck and arms with the provided soap two times per day morning and in the evening for 90 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Males and females of age group 18-60 years Subjects who are willing to give written informed consent.
Subjects with Fitzpatrick Skin types II to IV Subjects with hyper pigmentation disorders such as Melasma and lentigo (mild to moderate).
Patient is willing and able to comply with all trial requirements 
 
ExclusionCriteria 
Details  Having major treatment, including topical hydroquinone or tretinoin, cryotherapy, electro-surgery, trichloroacetic acid application, laser or intense pulsed light, in the 3 months before the beginning of the study Past history of allergy to whitening cosmetic products
Past history of atopic dermatitis Habit of going to the tanning salon or frequent sun exposure longer than 4 hours per day
Present history of mental diseases
Previous participation in a clinical trial within 6 months.
Pregnant or lactating woman
Certain medications that may interfere with the study medication (these will be identified by the study Investigator). 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Changes in score of the Melasma area and severity index (MASI) (Baseline to EOT) Mexameter analysis (Melanin,erythema contents) (Baseline to EOT) Chromameter (L,a and b values) (Baseline to EOT) To assess the efficacy of skin lightening soap for the treatment of hyper pigmentation in adults in comparison to base line by following parameters(Baseline to EOT)
Dermatologists assessment (Baseline to EOT) Shade card assessment(Baseline to EOT) 
Baseline to end of the treatment
(Day 90) 
 
Secondary Outcome  
Outcome  TimePoints 
Physician global improvement assessment scores.
Melasma Quality of life questionnaire before and after the treatment. (Baseline to EOT) To study the performance of the skin lightening soap in imparting the
skin whitening by subject self assessment during the visits (Baseline to EOT) - patient satisfaction using grading scale. 
All Visits 
 
Target Sample Size   Total Sample Size="15"
Sample Size from India="15" 
Final Enrollment numbers achieved (Total)= "15"
Final Enrollment numbers achieved (India)="15" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/11/2013 
Date of Study Completion (India) 06/02/2014 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   A Prospective, Open-labeled, Clinical Study to evaluate the efficacy and safety of a Skin Lightening Soap for the treatment of hyper pigmentation in adults.

Primary Objective: To assess the efficacy of „Skin Lightening Soap‟ for the treatment of hyper pigmentation disorders in adults. 

Secondary Objective: To evaluate the safety of Skin Lightening Soap‟ for the treatment of hyper pigmentation disorders in adults.

Primary endpoints Changes in score of the Melasma area and severity index (MASI) (Baseline to EOT) 

Mexameter analysis (Melanin,erythema contents) (Baseline to EOT) 

Chromameter (L,a and b values) (Baseline to EOT) 

To assess the efficacy of skin lightening soap for the treatment of hyper pigmentation in adults in comparison to base line by following parameters(Baseline to EOT)

Dermatologists assessment (Baseline to EOT) Shade card assessment(Baseline to EOT) 

Secondary Endpoints Physician global improvement assessment scores at Day 1 to Day 90 

skin whitening by subject self assessment during the visits (Baseline to EOT) - Patient satisfaction using grading scale.
 
Close